Health
State of Health Brazil results show China's Sinovac vaccine is just 50.4 percent effective against COVID-19
Just Earth News | @justearthnews | 14 Jan 2021, 09:56 pm Print
China COVID-19 Vaccine Brazilian clinical trials have unveiled that a COVID-19 vaccine developed by China's Sinovac has been found to be 50.4% effective, media reports said.
It shows the vaccine is significantly less effective than previous data suggested - barely over the 50% needed for regulatory approval, reports BBC.
The vaccine is one of the two which the Brazilian government has lined up.
Brazil is one of the worst-hit COVID-19 nations in the world.
Sinovac, a Beijing-based biopharmaceutical company, is behind CoronaVac, an inactivated vaccine. It works by using killed viral particles to expose the body's immune system to the virus without risking a serious disease response, reports BBC.
More Health
- Global obesity crisis deepens: One in five kids now overweight, study highlights
- Alarming projection: Global breast cancer cases could cross 3.5 million by 2050, shows study
- Exam stress to emotional distress: Study reveals the dark side of academic pressure
- Vegetarian diet linked to lower risk of five major cancers, study finds
- Ukraine’s health system under fire: Attacks spike 20% in 2025, WHO warns
-1763561110.jpg "Image of the day: November 19, 2025")
